top of page
Browse by category
Search

raRYGB can be a potent and safe option for standard practice
Roux-en-Y gastric bypass (raRYGB) with the MiniMIZER gastric ring (Bariatric Solutions International) resulted in enhanced weight loss...


Ratioing the resected gastric volume to the number of fired staplers predicts weight loss
Ratioing the resected gastric volume (RGV) to the number of staplers fired (SF) could be used to predict midterm weight loss, according...


Liraglutide after RYGB results in significant weight loss and resolution of obesity-related conditions
Adjunctive use of liraglutide at a dose of 3mg/day with conversional Roux-en-Y Gastric Bypass (cRYGB) results in significant weight loss,...

GLP-1 RAs show cardiovascular benefits beyond weight loss
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) continue to show cardiovascular benefits beyond weight loss, according to several...


AP39 compound delivers hydrogen sulfide directly to mitochondria cells induces weight loss
A study led by Jagiellonian University Medical College in Poland and the University of Exeter, UK, mice who were fed a high-fat diet and...

Tirzepatide results in greater weight loss in women than men
All doses of tirzepatide consistently reduced body weight in women and men, but women experienced greater weight loss, according to post...


Strong relationship between the increase in metabolic activity caused by once-daily GLP-1 and the amount of weight lost
A study carried out in St Vincent's University Hospital (SVUH) Dublin, Ireland, challenges the belief that weight-loss medications such...


LOWS study to investigate oxygen and weight status
Researchers at Pennington Biomedical have initiated a study that will explore weight loss associated with reduced oxygen environment. The...

Most Americans do not use GLP-1s long enough to see meaningful weight-loss
The largest study to date has reported that despite the explosion in demand for GLP-1s, 58% of patients discontinue use before reaching a...


Allurion reveals data showing lean mass gains in patients experiencing 14% weight loss
Allurion Technologies has announced the publication of a study demonstrating an average lean mass gain of 5.6% in patients with an...
Browse by tag






bottom of page